Abatacept, adalimumab, etanercept and tocilizumab for treating juvenile idiopathic arthritis

  • Technology appraisal guidance
  • TA373
  • Published: 

History

Documents created during the development process.

Expected publication

Final appraisal determination

Assessment report

Final protocol

Final scope

Final matrix

Comments table

Equality impact assessment - scoping

Provisional matrix - July 2014

Draft scope - July 2014